Literature DB >> 11423508

Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study.

J I Barzilay1, C F Spiekerman, L H Kuller, G L Burke, V Bittner, J S Gottdiener, F L Brancati, T J Orchard, D H O'Leary, P J Savage.   

Abstract

OBJECTIVE: Clinical cardiovascular disease (CVD) is highly prevalent among people with diabetes. However, there is little information regarding the prevalence of subclinical CVD and its relation to clinical CVD in diabetes and in the glucose disorders that precede diabetes. RESEARCH DESIGN AND METHODS: Participants in the Cardiovascular Health Study, aged > or = 65 years (n = 5,888), underwent vascular and metabolic testing. Individuals with known disease in the coronary, cerebral, or peripheral circulations were considered to have clinical disease. Those without any clinical disease in whom CVD was detected by ultrasonography, electrocardiography, or ankle arm index in any of the three vascular beds were considered to have isolated subclinical disease.
RESULTS: Approximately 30% of the cohort had clinical disease, and approximately 60% of the remainder had isolated subclinical disease. In those with normal glucose status, isolated subclinical disease made up most of the total CVD. With increasing glucose severity, the proportion of total CVD that was clinical disease increased; 75% of men and 66% of women with normal fasting glucose status had either clinical or subclinical CVD. Among those with known diabetes, the prevalence was approximately 88% (odds ratio [OR] 2.46 for men and 4.22 for women, P < 0.0001). There were intermediate prevalences and ORs for those with impaired fasting glucose status and newly diagnosed diabetes.
CONCLUSIONS: Isolated subclinical CVD is common among older adults. Glucose disorders are associated with an increased prevalence of total CVD and an increased proportion of clinical disease relative to subclinical disease.

Entities:  

Mesh:

Year:  2001        PMID: 11423508     DOI: 10.2337/diacare.24.7.1233

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  21 in total

1.  HIV and general cardiovascular risk.

Authors:  Bernadette Capili; Joyce K Anastasi; Olugbenga Ogedegbe
Journal:  J Assoc Nurses AIDS Care       Date:  2011-02-01       Impact factor: 1.354

Review 2.  Atherosclerotic cardiovascular disease in older adults with diabetes mellitus.

Authors:  Joshua I Barzilay; Kenneth J Mukamal; Jorge R Kizer
Journal:  Clin Geriatr Med       Date:  2014-11-15       Impact factor: 3.076

3.  The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.

Authors:  William H Herman; Thomas J Hoerger; Michael Brandle; Katherine Hicks; Stephen Sorensen; Ping Zhang; Richard F Hamman; Ronald T Ackermann; Michael M Engelgau; Robert E Ratner
Journal:  Ann Intern Med       Date:  2005-03-01       Impact factor: 25.391

4.  A novel transcriptional mechanism of cell type-specific regulation of vascular gene expression by glucose.

Authors:  Priya Raman; Christy Harry; Malory Weber; Irene Krukovets; Olga I Stenina
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12-09       Impact factor: 8.311

5.  Lipoprotein-associated phospholipase A(2) and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study.

Authors:  T L Nelson; A Kamineni; B Psaty; M Cushman; N S Jenny; J Hokanson; C Furberg; K J Mukamal
Journal:  Diabetologia       Date:  2010-11-20       Impact factor: 10.122

6.  Diabetes, insulin resistance and atherosclerosis surrogates in patients with coronary atherosclerosis.

Authors:  Hyun-Woong Park; Taek Geun Kown; Ki-Young Kim; Jang-Ho Bae
Journal:  Korean Circ J       Date:  2010-02-23       Impact factor: 3.243

Review 7.  [Evidence-based recommendations on primary diagnostics of peripheral arterial occlusive disease in geriatric patients].

Authors:  C Ploenes; H Görtz; T Heimig; M Meisel; C Naumann; R Sultzer
Journal:  Z Gerontol Geriatr       Date:  2009-09-10       Impact factor: 1.281

Review 8.  Inflammation and emerging risk factors in diabetes mellitus and atherosclerosis.

Authors:  Pierre Theuma; Vivian A Fonseca
Journal:  Curr Diab Rep       Date:  2003-06       Impact factor: 4.810

9.  Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study.

Authors:  A Scuteri; S S Najjar; M Orru'; G Albai; J Strait; K V Tarasov; M G Piras; A Cao; D Schlessinger; M Uda; E G Lakatta
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-03-25       Impact factor: 4.222

10.  Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM.

Authors:  Xingyu Nie; Gwendalyn J Randolph; Andrew Elvington; Nilantha Bandara; Alexander Zheleznyak; Robert J Gropler; Pamela K Woodard; Suzanne E Lapi
Journal:  Nucl Med Biol       Date:  2016-05-30       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.